CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Stoke Therapeutics Fiscal Q4 2025 Earnings Report | CapyFin

Stoke Therapeutics

STOK · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 in 1d Q3 2025 -10.06%Q2 2025 +24.78%Q1 2025 +1.24%Q4 2024 -1.44%Q3 2024 +1.15%Q2 2024 -0.63%Q1 2024 -0.67%Q4 2023 +63.33%Q3 2023 +6.96%Q2 2023 -9.31%Q1 2023 +25.92%Q4 2022 +4.53%Q3 2022 -20.02%Q2 2022 +31.69%Q1 2022 +2.05%Q4 2021 -1.64%Q3 2021 +2.96%Q2 2021 -1.44%Q1 2021 +11.34%Q4 2020 +6.77%Q3 2020 -0.51%Q2 2020 +4.74%Q1 2020 +15.31%Q4 2019 -3.87%Q3 2019 -11.08%Q2 2019 0.00%Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018

Mar 17

Stoke Therapeutics Q4 2025 Earnings Report

Stoke Therapeutics

Unlock previous datapoints

Stoke Therapeutics

Unlock previous datapoints

Loading...

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Stoke Therapeutics

Key Statistics

Market Cap

$1.97B

P/E Ratio

39.08

Sector

N/A

Industry

N/A

52-Week High

$38.4

52-Week Low

$5.89